Ifp Advisors, Inc Biotechnology

Ifp Advisors, Inc

$2.91 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ALT Altimmune, Inc.	$285M	$2,000 0.0% of portfolio	346	Q4 2024 Added 73.0%
CORT Corcept Therapeutics Inc	$6.28B	$2,000 0.0% of portfolio	59	Q4 2024 Added 22.92%
GMAB Genmab A/S	$13B	$2,000 0.0% of portfolio	113	Q4 2024 Added 54.79%
ONCY Oncolytics Biotech Inc	$36.5M	$2,000 0.0% of portfolio	2,504	Q4 2024 Added 0.16%
VCYT Veracyte, Inc.	$2.28B	$2,000 0.0% of portfolio	55	Q4 2024 Reduced 97.22%
ADAP Adaptimmune Therapeutics PLC	$47.4M	$1,000 0.0% of portfolio	3,023	Q2 2024 New
ALVR Allovir, Inc.	$913M	$1,000 0.0% of portfolio	3,000	Q2 2024 New
TRDA Entrada Therapeutics, Inc.	$329M	$1,000 0.0% of portfolio	87	Q4 2024 New
ORMP Oramed Pharmaceuticals Inc.	$92.8M	$1,000 0.0% of portfolio	500	Q1 2024 Reduced 66.67%
VIR Vir Biotechnology, Inc.	$919M	$1,000 0.0% of portfolio	219	Q4 2024 Added 9.5%
PRTA Prothena Corp Public LTD CO	$609M	$1,000 0.0% of portfolio	132	Q4 2024 New
ABSI Absci Corp	$279M	$0 0.0% of portfolio	0	Q4 2024 New
ADGI Adagio Therapeutics, Inc.	$505M	$0 0.0% of portfolio	7	Q4 2024 New
ADPT Adaptive Biotechnologies Corp	$1.2B	$0 0.0% of portfolio	28	Q4 2024 New
AGIO Agios Pharmaceuticals, Inc.	$1.72B	$0 0.0% of portfolio	3	Q4 2024 New
AKRO Akero Therapeutics, Inc.	$2.1B	$0 0.0% of portfolio	1	Q4 2024 New
ALDX Aldeyra Therapeutics, Inc.	$384M	$0 0.0% of portfolio	13	Q4 2024 New
ALEC Alector, Inc.	$111M	$0 0.0% of portfolio	4	Q4 2024 New
AMRN Amarin Corp Plcuk	$185M	$0 0.0% of portfolio	1,592	Q1 2023 Reduced 84.54%
ANNX Annexon, Inc.	$116M	$0 0.0% of portfolio	0	Q4 2024 New
APLT Applied Therapeutics Inc.	$27.4M	$0 0.0% of portfolio	1	Q4 2024 New
ABUS Arbutus Biopharma Corp	$492M	$0 0.0% of portfolio	0	Q4 2024 New
ACLX Arcellx, Inc.	$3.04B	$0 0.0% of portfolio	2	Q4 2024 New
ARDX Ardelyx, Inc.	$793M	$0 0.0% of portfolio	26	Q4 2024 New
RCUS Arcus Biosciences, Inc.	$645M	$0 0.0% of portfolio	65	Q4 2024 New
ARQT Arcutis Biotherapeutics, Inc.	$1.02B	$0 0.0% of portfolio	13	Q4 2024 New
ARCT Arcturus Therapeutics Holdings Inc.	$342M	$0 0.0% of portfolio	0	Q4 2024 New
ARVN Arvinas, Inc.	$466M	$0 0.0% of portfolio	0	Q4 2024 New
ASND Ascendis Pharma A/S	$9.26B	$0 0.0% of portfolio	1	Q4 2024 New
ATXS Astria Therapeutics, Inc.	$97.3M	$0 0.0% of portfolio	0	Q4 2024 New
AVIR Atea Pharmaceuticals, Inc.	$268M	$0 0.0% of portfolio	0	Q4 2024 New
AURA Aura Biosciences, Inc.	$220M	$0 0.0% of portfolio	10	Q4 2024 New
CDMO Avid Bioservices, Inc.	$776M	$0 0.0% of portfolio	2	Q4 2024 New
BEAM Beam Therapeutics Inc.	$1.64B	$0 0.0% of portfolio	0	Q4 2024 New
BCRX Biocryst Pharmaceuticals Inc	$1.48B	$0 0.0% of portfolio	53	Q4 2024 New
BMEA Biomea Fusion, Inc.	$84.1M	$0 0.0% of portfolio	11	Q4 2024 Reduced 98.53%
BDTX Black Diamond Therapeutics, Inc.	$64.7M	$0 0.0% of portfolio	0	Q4 2024 New
BPMC Blueprint Medicines Corp	$5.3B	$0 0.0% of portfolio	4	Q4 2024 Reduced 98.84%
BBIO Bridge Bio Pharma, Inc.	$5.15B	$0 0.0% of portfolio	14	Q4 2024 Reduced 99.03%
CABA Cabaletta Bio, Inc.	$50.5M	$0 0.0% of portfolio	0	Q4 2024 New
CRBU Caribou Biosciences, Inc.	$63.3M	$0 0.0% of portfolio	41	Q4 2024 New
SAVA Cassava Sciences Inc	$114M	$0 0.0% of portfolio	19	Q4 2024 Added 26.67%
CPRX Catalyst Pharmaceuticals, Inc.	$2.49B	$0 0.0% of portfolio	23	Q4 2024 New
CELC Celcuity Inc.	$152M	$0 0.0% of portfolio	0	Q4 2024 New
CDXC Chroma Dex Corp.	$539M	$0 0.0% of portfolio	2	Q4 2024 New
CDXS Codexis, Inc.	$167M	$0 0.0% of portfolio	1	Q4 2024 New
COGT Cogent Biosciences, Inc.	$471M	$0 0.0% of portfolio	0	Q4 2024 New
CHRS Coherus Bio Sciences, Inc.	$80.1M	$0 0.0% of portfolio	224	Q4 2024 New
CMPX Compass Therapeutics, Inc.	$234M	$0 0.0% of portfolio	16	Q4 2024 New
CRMD Cor Medix Inc.	$452M	$0 0.0% of portfolio	5	Q4 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.